Growth Metrics

ProPhase Labs (PRPH) Current Deferred Revenue (2018 - 2025)

Historic Current Deferred Revenue for ProPhase Labs (PRPH) over the last 8 years, with Q3 2025 value amounting to $1.4 million.

  • ProPhase Labs' Current Deferred Revenue fell 1657.56% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 1657.56%. This contributed to the annual value of $1.7 million for FY2024, which is 5148.57% down from last year.
  • ProPhase Labs' Current Deferred Revenue amounted to $1.4 million in Q3 2025, which was down 1657.56% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' Current Deferred Revenue registered a high of $3.9 million during Q3 2022, and its lowest value of $233000.0 during Q2 2021.
  • For the 5-year period, ProPhase Labs' Current Deferred Revenue averaged around $2.2 million, with its median value being $1.8 million (2024).
  • As far as peak fluctuations go, ProPhase Labs' Current Deferred Revenue soared by 136480.69% in 2022, and later tumbled by 5148.57% in 2024.
  • Quarter analysis of 5 years shows ProPhase Labs' Current Deferred Revenue stood at $2.9 million in 2021, then rose by 22.49% to $3.6 million in 2022, then fell by 2.78% to $3.5 million in 2023, then crashed by 51.49% to $1.7 million in 2024, then dropped by 19.08% to $1.4 million in 2025.
  • Its Current Deferred Revenue was $1.4 million in Q3 2025, compared to $1.4 million in Q2 2025 and $1.6 million in Q1 2025.